Standard Biotools (LAB) EBT Growth (3y) (2013 - 2026)
Standard Biotools (LAB) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 17.92% |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn | -8.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.59% |
| Mar 31, 2026 | 4.12% |
| Dec 31, 2025 | -65.78% |
| Sep 30, 2025 | -2.96% |
| Jun 30, 2025 | 34.53% |
| Mar 31, 2025 | 32.64% |
| Sep 30, 2024 | 25.82% |
| Jun 30, 2024 | 12.68% |
| Mar 31, 2024 | -16.05% |
| Dec 31, 2023 | 40.99% |
| Sep 30, 2023 | -49.72% |
| Jun 30, 2023 | -5.74% |
| Mar 31, 2023 | 0.16% |
| Dec 31, 2022 | 143.45% |
| Sep 30, 2022 | -28.95% |
| Jun 30, 2022 | -63.54% |
| Mar 31, 2022 | -44.60% |
| Sep 30, 2021 | -50.95% |
| Jun 30, 2021 | -32.38% |
| Mar 31, 2021 | -12.40% |